07.03.2012

China: Sourcing Partnerships

Role of China - China's importance to the global pharmaceutical sourcing industry is no longer in question. Now the issue is how to materialize China's potential value via partnership development. In the past 10 years, the cost to commercialize a new drug has increased to about $1.5 billion.

The change has driven the pharmaceutical outsourcing investment to about $36 billion in 2011 and grown the CRO/CMO (contract research organization/contract manufacturing organization) market dramatically, particularly in China and India.
more09.09.2011

Bristol-Myers Squibb Completes Amira Acquisition

Bristol-Myers Squibb said Thursday that it has completed its acquisition of privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. more01.06.2010

Protecting the Crown Jewels

No Risk - Whether you are outsourcing product development or manufacture, it is crucial to ensure that you have a clear understanding of all intellectual property aspects of the transaction, and that you put in place a well-drafted contract that protects your intellectual property (IP) and ensures adequate rights in relation to any new IP generated. A failure to do so can have many consequences, but at its worst it will mean that you won't own new IP that you had expected to own, and your confidential information could have found its way into the public domain. more